Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06855043
PHASE1/PHASE2

Little Lungs Study

Sponsor: University of Wisconsin, Madison

View on ClinicalTrials.gov

Summary

This clinical trial is being done to evaluate the safety and clinical response of late surfactant treatment with budesonide in extremely preterm infants requiring mechanical ventilation at 7-14 days of age.

Official title: Pilot Randomized Controlled Trial of Late Surfactant Therapy With Budesonide for Prevention of Bronchopulmonary Dysplasia

Key Details

Gender

All

Age Range

7 Days - 14 Days

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-09

Completion Date

2029-03

Last Updated

2026-01-27

Healthy Volunteers

No

Interventions

DRUG

Calfactant

Participants will receive 2 daily doses of Calfactant (3 ml/kg) intratracheal administration

DRUG

Budesonide

Participants will receive 2 daily doses of Budesonide (0.25mg/kg) intratracheal administration.

Locations (2)

Meriter Hospital

Madison, Wisconsin, United States

American Family Children's Hospital

Madison, Wisconsin, United States